<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Pediatric prolactinoma-associated pituitary apoplexy presenting with acute visual loss: a case report, literature review, and management strategy

dc.contributor.authorYilmaz, Yunus Emre
dc.contributor.authorEmrahoglu, Muhammed Erkan
dc.contributor.authorErdeve, Senay Savas
dc.contributor.authorBala, Keziban Asli
dc.contributor.authorAkyuz, Tuba Kara
dc.contributor.authorYilmaz, Sukriye
dc.contributor.authorYetisgin, Efe
dc.contributor.authorKertmen, Huseyin Hayri
dc.date.accessioned2026-11-05T11:01:24Z
dc.date.issued2026
dc.description.abstractObjectives Hemorrhagic pituitary apoplexy (PA) in children is exceedingly rare, with approximately 32 cases reported since 1980. Current guidelines recommend cabergoline as first-line therapy; however, acute complete visual loss mandates emergency surgical decompression. No guideline defines the optimal extent of resection, despite gross total resection carrying a 48-54 % risk of panhypopituitarism.Case presentation An 11-year-old prepubertal girl presented with a 2-day history of complete right-eye visual loss. Serum prolactin was 987 mu g/L, and MRI demonstrated a hemorrhagic sellar-suprasellar mass compressing the optic chiasm. Emergency endoscopic transsphenoidal surgery was performed with an intentionally limited strategy - hematoma evacuation, optic decompression, and partial debulking - deliberately avoiding aggressive capsular dissection. Histopathology confirmed prolactinoma. Vision was fully restored immediately after extubation, with near-complete visual field recovery on postoperative day 5 (VFI 98 %). Adrenocortical function was preserved. Central hypothyroidism developed, and levothyroxine was initiated. Cabergoline (0.25 mg/week) was started on postoperative day 5, achieving a 93.7 % prolactin reduction by day 20 (987 -> 61.9 mu g/L).Conclusions In pediatric prolactinoma-associated PA requiring emergency surgery, a decompression-first strategy prioritizing visual rescue and tissue diagnosis over gross total resection may reduce the risk of panhypopituitarism, with residual tumor subsequently managed with cabergoline. The rapid biochemical response documented here supports this approach, though multicenter prospective evaluation is required.
dc.identifier.doi10.1515/jpem-2026-0379
dc.identifier.issn0334-018X
dc.identifier.issn2191-0251
dc.identifier.urihttps://doi.org/10.1515/jpem-2026-0379
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/10721
dc.identifier.wosWOS:001904138300001
dc.language.isoen
dc.publisherWALTER DE GRUYTER GMBH
dc.relation.hasversion10.1515/jpem-2026-0379
dc.relation.ispartofJOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
dc.subjectpituitary apoplexy
dc.subjectprolactinoma
dc.subjectoptic decompression
dc.subjectEndocrinology & Metabolism
dc.subjectPediatrics
dc.titlePediatric prolactinoma-associated pituitary apoplexy presenting with acute visual loss: a case report, literature review, and management strategy
dc.typeArticle
oaire.citation.editionScience Citation Index Expanded (SCI-EXPANDED)
person.identifier.ridOIS-3286-2025
person.identifier.ridQJV-7728-2026
person.identifier.ridQIU-2375-2026

Files

Collections